Boyd Susan
Harm Reduct J. 2013 Apr 18;10:6. doi: 10.1186/1477-7517-10-6.
This article highlights the experiences of a unique group. In January 2011, Dave Murray organized a group of participants from the North American Opiate Medication Initiative (NAOMI) heroin-assisted treatment clinical trials from 2005 to 2008 in the Downtown Eastside of Vancouver (DTES), B.C., Canada. The NAOMI Patients Association (NPA) is an independent group that currently meets every Saturday in the DTES. Currently, all members of the NPA are former participants in the heroin stream of the clinical trial. The NPA offers support, education, and advocacy to its members.
Drawing on brainstorming sessions and focus groups that were conducted in the summer of 2011, this paper highlights the experiences of NPA members in their own words.
The findings provide a lens to understand how becoming a research subject for the NAOMI trial impacted the lives of NPA members, both positive and negative. The NPA members discuss ethics, consent, recommendations for future HAT programs and studies, and ongoing advocacy.
本文重点介绍了一个独特群体的经历。2011年1月,戴夫·默里组织了一群来自北美阿片类药物治疗倡议(NAOMI)的参与者,他们参与了2005年至2008年在加拿大不列颠哥伦比亚省温哥华市中心东区(DTES)进行的海洛因辅助治疗临床试验。NAOMI患者协会(NPA)是一个独立团体,目前每周六在DTES聚会。目前,NPA的所有成员都是该临床试验海洛因治疗组的前参与者。NPA为其成员提供支持、教育和宣传。
本文借鉴了2011年夏天举行的头脑风暴会议和焦点小组讨论的内容,用NPA成员自己的话重点介绍了他们的经历。
研究结果为理解成为NAOMI试验的研究对象如何对NPA成员的生活产生积极和消极影响提供了一个视角。NPA成员讨论了伦理、同意、对未来海洛因辅助治疗项目和研究的建议以及持续的宣传活动。